Ledger.Open graph →
SEC Form D · filed October 28, 2022

Aravive, Inc

Offering
$41.6M
Sold
$41.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Fredric N. Eshelman · Houston, TXExec · DirectorRobert B. Geller · Houston, TXExecRudy N. Howard · Houston, TXExecSigurd C. Kirk · Houston, TXDirectorMichael W. Rogers · RIVER FALLS, WIDirectorPeter T. Ho · Houston, TXDirectorGail Mcintyre · Houston, TXExec · DirectorLeonard S. Dove · Houston, TXExecEric B. Zhang · Houston, TXDirectorAmato B. Giaccia · Houston, TXDirectorJohn A. Hohnecker · Houston, TXDirectorRudy N. Howard · Houston, TXExecFredric N. Eshelman · Houston, TXExec · DirectorSigurd C. Kirk · Houston, TXDirectorMichael W. Rogers · Houston, TXDirectorPeter T. Ho · Houston, TXDirectorRobert B. Geller · Houston, TXExecGail Mcintyre · Monmouth Junction, NJExec · DirectorLeonard S. Dove · Houston, TXExecEric B. Zhang · Houston, TXDirectorAmato B. Giaccia · Houston, TXDirectorJohn A. Hohnecker · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗